Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Tissue Repair Ltd ( (AU:TRP) ) has issued an update.
Tissue Repair Limited has responded to an ASX price query, confirming that it is not aware of any undisclosed information that could explain recent trading activity in its securities. The company asserts compliance with listing rules and confirms that its responses have been authorized under its continuous disclosure policy.
More about Tissue Repair Ltd
Tissue Repair Limited (ASX: TRP) is a Phase 3 biotechnology company focused on developing second-generation wound healing agents. The company is advancing its lead drug candidate TR987® for chronic wounds and commercializing TR Pro+®, a topical treatment designed to accelerate healing and improve skin quality following cosmetic or medical procedures. Its proprietary Glucoprime® API supports a growing pipeline of therapeutic solutions.
Average Trading Volume: 86,324
Technical Sentiment Signal: Buy
Current Market Cap: A$19.65M
Find detailed analytics on TRP stock on TipRanks’ Stock Analysis page.